Molecular Partners AG

Informe acción SWX:MOLN

Capitalización de mercado: CHF 188.0m

Salud financiera de hoja de balance de Molecular Partners

Salud financiera controles de criterios 6/6

Molecular Partners tiene un patrimonio de los accionistas total de CHF138.8M y una deuda total de CHF0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son CHF154.2M y CHF15.4M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

CHF 0

Deuda

Ratio de cobertura de interesesn/a
EfectivoCHF 143.62m
PatrimonioCHF 138.78m
Total pasivoCHF 15.43m
Activos totalesCHF 154.21m

Actualizaciones recientes sobre salud financiera

Recent updates

We're Keeping An Eye On Molecular Partners' (VTX:MOLN) Cash Burn Rate

Sep 10
We're Keeping An Eye On Molecular Partners' (VTX:MOLN) Cash Burn Rate

We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Apr 11
We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?

Jan 09
Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?

Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation

Sep 08
Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation

Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023

Jun 23
Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023

What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today

Aug 31
What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today

Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

May 09
Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts

Dec 26
Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts

We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely

Jun 24
We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely

Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability

Mar 09
Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability

Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts

Feb 10
Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts

Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

Jan 21
Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?

Dec 17
How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CHF149.5M) de MOLN superan a sus pasivos a corto plazo (CHF10.4M).

Pasivo a largo plazo: Los activos a corto plazo de MOLN (CHF149.5M) superan a sus pasivos a largo plazo (CHF5.0M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: MOLN está libre de deudas.

Reducción de la deuda: MOLN no tenía deudas hace 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: MOLN tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.

Pronóstico de cash runway: MOLN dispone de suficiente cash runway para 1.9 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 1.7% cada año.


Descubre empresas con salud financiera